GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,065,136 | -7.5% | 26,877 | -10.5% | 0.21% | -13.2% |
Q3 2022 | $1,151,000 | +11.7% | 30,016 | -0.2% | 0.24% | +13.6% |
Q2 2022 | $1,030,000 | +2.8% | 30,065 | +7.4% | 0.21% | +15.1% |
Q1 2022 | $1,002,000 | +11.7% | 27,994 | +1.7% | 0.19% | +11.4% |
Q4 2021 | $897,000 | -38.6% | 27,529 | -12.5% | 0.17% | -26.4% |
Q3 2021 | $1,461,000 | +4.4% | 31,453 | +2.5% | 0.23% | -0.4% |
Q2 2021 | $1,399,000 | +23.2% | 30,683 | +0.6% | 0.23% | +11.8% |
Q1 2021 | $1,136,000 | -4.3% | 30,505 | +4.3% | 0.20% | -6.8% |
Q4 2020 | $1,187,000 | +4.8% | 29,248 | +1.8% | 0.22% | -5.2% |
Q3 2020 | $1,133,000 | +13.0% | 28,737 | -2.9% | 0.23% | -21.4% |
Q2 2020 | $1,003,000 | – | 29,597 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |